RxDoctor Payments Data

Carly Hazzard Andrews, NP

Nurse Practitioner · Greenville, MSNPI 1194211094

Payments from drug & device makers

$1,432in general payments, 2019–2025

Across 76 payments — averaging $18.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$394
  • Novartis$229
  • Novo Nordisk$136
  • Boehringer Ingelheim$101
  • Medtronic$85
  • Pfizer$77
  • plus $410 from 15 others

What the payments were for

  • Food & beverage$1,432100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,432 in reported general payments places this provider in the 80th percentile of 1,090 nurse practitioner providers in Mississippi.

See all nurse practitioner providers in Mississippi

Medicare billing

Part B allowed, 2024
$27,936
Medicare patients
131
Services billed
2,077

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin55$43,047
XareltoRivaroxaban58$39,861
EntrestoSacubitril/Valsartan31$29,204
EliquisApixaban27$23,245
FarxigaDapagliflozin Propanediol27$20,614
TradjentaLinagliptin13$7,473
Breo ElliptaFluticasone/Vilanterol11$4,188
Rosuvastatin Calcium141$1,465
Valsartan30$1,034
Pravastatin Sodium69$741
Potassium Chloride56$727
ClopidogrelClopidogrel Bisulfate93$685
Losartan Potassium89$601
Albuterol Sulfate HfaAlbuterol Sulfate21$579
Atorvastatin Calcium80$500

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$101$50,52068 claims
Johnson & JohnsonXarelto$15$39,86158 claims
NovartisEntresto$229$29,20431 claims
PfizerEliquis$77$23,24527 claims
AstraZenecaFarxiga$394$20,61427 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,090 nurse practitioner providers in Mississippi.

Other nurse practitioner in Greenville

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →